Comparison Between Two Different Dosages of Remifentanil During Colonoscopy

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this randomized double-blind trial is to define the correct dosage of Remifentanil during operative and diagnostic endoscopic procedures. In particular we want to analyze if the administration of Remifentanil by PCSA (Patient Controlled Sedation and Analgesia) is a good method during colonoscopy, evaluating pain control, discharge time and side effects.

90 patients undergoing colonoscopy will be enrolled.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ospedale San Raffaele
• Treatments: Meperidine; Remifentanil

Criteria

Inclusion Criteria:

• Adult Patients

• Diagnostic and Operative Colonoscopy

• ASA Physical Status I-II

Exclusion Criteria:

• Age < 18 years